Obesity drug shows promise in curbing cravings and stress eating
NCT ID NCT04779697
First seen Feb 19, 2026 · Last updated Jun 19, 2026 · Updated 28 times
Summary
This study tested a GLP-1 drug (a type of medication that affects appetite) against a placebo in 96 adults with obesity. The goal was to see if the drug could reduce cravings, hunger, stress, and food intake. Results suggest the drug may help control eating behaviors and support weight management.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The Yale Stress Center: Yale University
New Haven, Connecticut, 06519, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.